Evidence map›Paper›PMID 30275958›Full record

ArticleJMM case reports2018

Extensively drug-resistant (XDR)

Paul Ríos, Claudio Rocha, William Castro, Maria Vidal, Enrique Canal, Manuela Bernal, Nathanael D Reynolds, Drake H Tilley, Mark P Simons

Abstract readCase Reports
In one paragraph

Article in JMM case reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Extensively drug-resistantFrontiers in microbiology · 2024
    Article
  5. Characterization of a novel bullet-shaped lytic bacteriophage against extensively drug-resistantVeterinary research forum : an international quarterly journal · 2021
    Article
  6. Mobile Carbapenemase Genes inFrontiers in microbiology · 2021
    Review
  7. First report of bla GES-1 in Proteus mirabilis clinical isolates.Revista da Sociedade Brasileira de Medicina Tropical · 2021
    Article
  8. [Panorama of carbapenemases in PeruUm panorama das carbapenemases presentes no Peru].Revista panamericana de salud publica = Pan American journal of public health · 2020
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Paul RíosU.S. Naval Medical Research Unit No.6 (NAMRU-6), Lima, Perú.
Claudio RochaU.S. Naval Medical Research Unit No.6 (NAMRU-6), Lima, Perú.
William CastroCentro Médico Naval "Cirujano Mayor Santiago Távara (CEMENA)", Lima, Perú.
Maria VidalCentro Médico Naval "Cirujano Mayor Santiago Távara (CEMENA)", Lima, Perú.
Enrique CanalU.S. Naval Medical Research Unit No.6 (NAMRU-6), Lima, Perú.
Manuela BernalU.S. Naval Medical Research Unit No.6 (NAMRU-6), Lima, Perú.
Nathanael D ReynoldsU.S. Naval Medical Research Unit No.6 (NAMRU-6), Lima, Perú.
Drake H TilleyNaval Medical Center, San Diego, USA.
Mark P SimonsU.S. Naval Medical Research Unit No.6 (NAMRU-6), Lima, Perú.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionCASE PRESENTATION: An 83 year old female was admitted in 2012 to the Peruvian Naval Hospital, Centro Médico Naval 'Cirujano Mayor Santiago Távara' (CEMENA), in Lima, Peru. A midstream urine sample was collected and sent to the local CEMENA laboratory for routine urine culture.

conclusionTo our knowledge, this is the first report of a

Indexed as

carbapenemasemetallo-β-lactamase

Identifiers

PMID30275958
PMCPMC6159545

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.